China Merchants Fund Leads $25M Round In Gene-Editing Start-Up Qihan Biotech

Qihan Biotech, a Hangzhou-based biotech startup focused on organ transplantation, announced on Monday that it has raised US$25.5 million in a series A+ funding round. The round is led by Hong Kong-based CMBI (CMB International Capital Corporation Limited), a financial service company under China Merchants Bank (CMB), with participation from Chinese investment fund Legend Star, […]

China Merchants Fund Leads $25M Round In Gene-Editing Start-Up Qihan Biotech comes originally from China Money Network. All Rights Reserved.

Read the original article: China Money Network